All data are based on the daily closing price as of December 30, 2025
s
Sunmax Biotechnology
4728.TWO
12.75 USD
0.05
+0.39%
Overview
Last close
12.75 usd
Market cap
694.65M usd
52 week high
16.58 usd
52 week low
7.93 usd
Target price
N/A usd
Valuation
P/E
30.3802
Forward P/E
N/A
Price/Sales
10.8949
Price/Book Value
15.0257
Enterprise Value
673.41M usd
EV/Revenue
18.6941
EV/EBITDA
22.0431
Key financials
Revenue TTM
63.76M usd
Gross Profit TTM
50.42M usd
EBITDA TTM
33.71M usd
Earnings per Share
0.42 usd
Dividend
0.37 usd
Total assets
62.30M usd
Net debt
N/A usd
About
Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan.